Literature DB >> 33926138

The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial.

Gennaro Nappo1, Domenico Borzomati2, Alessandro Zerbi1,3, Paola Spaggiari4, Ugo Boggi4,5, Daniela Campani6, Sławomir Mrowiec7, Łukasz Liszka8, Alessandro Coppola2, Michela Amato9, Tommasangelo Petitti10, Fabio Vistoli4,5, Marco Montorsi3,11, Giuseppe Perrone9, Roberto Coppola2, Damiano Caputo2.   

Abstract

BACKGROUND: There is extreme heterogeneity in the available literature on the determination of R1 resection rate after pancreatoduodenectomy (PD); consequently, its prognostic role is still debated. The aims of this multicenter randomized study were to evaluate the effect of sampling and clearance definition in determining R1 rate after PD for periampullary cancer and to assess the prognostic role of R1 resection.
METHODS: PD specimens were randomized to Leeds Pathology Protocol (LEEPP) (group A) or the conventional method adopted before the study (group B). R1 rate was determined by adopting 0- and 1-mm clearance; the association between R1, local recurrence (LR) and overall survival (OS) was also evaluated.
RESULTS: One-hundred-sixty-eight PD specimens were included. With 0 mm clearance, R1 rate was 26.2% and 20.2% for groups A and B, respectively; with 1 mm, R1 rate was 60.7% and 57.1%, respectively (p > 0.05). Only in group A was R1 found to be a significant prognostic factor: at 0 mm, median OS was 36 and 20 months for R0 and R1, respectively, while at 1 mm, median OS was not reached and 30 months. At multivariate analysis, R1 resection was found to be a significant prognostic factor independent of clearance definition only in the case of the adoption of LEEPP.
CONCLUSIONS: The 1 mm clearance is the most effective factor in determining the R1 rate after PD. However, the pathological method is crucial to accurately evaluate its prognostic role: only R1 resections obtained with the adoption of LEEPP seem to significantly affect prognosis.

Entities:  

Keywords:  R1 resection; margin status; microscopic residual tumor; minimum clearance; pancreatoduodenectomy; pathological evaluation

Year:  2021        PMID: 33926138     DOI: 10.3390/cancers13092097

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  23 in total

1.  Microscopic Residual Tumor After Pancreaticoduodenectomy: Is Standardization of Pathological Examination Worthwhile?

Authors:  Domenico Borzomati; Giuseppe Perrone; Gennaro Nappo; Sergio Valeri; Michela Amato; Tommasangelo Petitti; Andrea Onetti Muda; Roberto Coppola
Journal:  Pancreas       Date:  2016 May-Jun       Impact factor: 3.327

2.  A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen.

Authors:  Mahmoud A Khalifa; Vlad Maksymov; Corwyn H Rowsell; Sherif Hanna
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

4.  Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.

Authors:  Giovanni Butturini; Deborah D Stocken; Moritz N Wente; Hans Jeekel; Johaness H G Klinkenbijl; Kåre E Bakkevold; Tadahiro Takada; Hirano Amano; Christos Dervenis; Claudio Bassi; Markus W Büchler; John P Neoptolemos
Journal:  Arch Surg       Date:  2008-01

5.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

6.  Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.

Authors:  J K Pine; B Haugk; S M Robinson; A Darne; C Wilson; G Sen; J J French; S A White; D M Manas; R M Charnley
Journal:  Pancreatology       Date:  2020-01-10       Impact factor: 3.996

7.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

9.  Axial slicing versus bivalving in the pathological examination of pancreatoduodenectomy specimens (APOLLO): a multicentre randomized controlled trial.

Authors:  Stijn van Roessel; Eline C Soer; Susan van Dieren; Lianne Koens; Marie Louise F van Velthuysen; Michael Doukas; Bas Groot Koerkamp; Arantza Fariña Sarasqueta; Carolien M Bronkhorst; G Mihaela Raicu; Karel C Kuijpers; Cornelis A Seldenrijk; Hjalmar C van Santvoort; I Quintus Molenaar; Rachel S van der Post; Martijn W J Stommel; Olivier R Busch; Marc G Besselink; Lodewijk A A Brosens; Joanne Verheij
Journal:  HPB (Oxford)       Date:  2021-01-21       Impact factor: 3.647

Review 10.  Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens.

Authors:  Eline Soer; Lodewijk Brosens; Marc van de Vijver; Frederike Dijk; Marie-Louise van Velthuysen; Arantza Farina-Sarasqueta; Hans Morreau; Johan Offerhaus; Lianne Koens; Joanne Verheij
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

View more
  2 in total

Review 1.  Current Pathology Model of Pancreatic Cancer.

Authors:  Krzysztof Szymoński; Katarzyna Milian-Ciesielska; Ewelina Lipiec; Dariusz Adamek
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

2.  Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5th edition).

Authors:  Maoquan Li
Journal:  J Interv Med       Date:  2021-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.